Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis

Ocular Immunology and Inflammation

Volumn 13, Issue 5, 2005, Pages 353-360

  Yu, Ellen N ^a   Meniconi, Margherita E ^a   Tufail, Fehma ^a   Baltatzis, Stefanos ^a   Foster, C Stephen ^a,c   Christen, William G ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

Author keywords

Immunomodulatory therapy; Iridocyclitis; Juvenile idiopathic arthritis; Uveitis

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONSULTATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG RESISTANCE; ENZYME DEFECT; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IRIDOCYCLITIS; JUVENILE RHEUMATOID ARTHRITIS; LEUKOPENIA; MALE; NAUSEA; STATISTICAL ANALYSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; UVEITIS; VISION; VISUAL ACUITY; VOMITING;

ADOLESCENT; ADULT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IRIDOCYCLITIS; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 28244445449     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940590951061     Document Type: Article

References (27)

1. Towner SR, Michel Jr CJ, O'Fallon WM, et al. The epidemiology of juvenile rheumatoid arthritis in Rochester, Minnesota. Arthritis Rheum. 1983;26:1208.
2. Cassidy JT, Petty RE. Textbook of Pediatric Rheumatology. 3rd ed. Philadelphia: W.B. Saunders, 1994.
3. Tugal-Tutkun I, Havrlikova K, Power WJ, Foster CS. Changing patterns in uveitis of childhood. Ophthalmology. 1996;103:375-383.
4. Wolf MD, Lichter MD, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology. 1987;94:1242-1248.
5. Kanski JJ. Uveitis in juvenile chronic arthritis: incidence, clinical features and prognosis. Eye. 1988;2:641-645.
6. Spalter HF. The visual prognosis in juvenile rheumatoid arthritis. Trans Am Ophthalmol Soc. 1975;73:554-570.
7. Key iii SN, Kimura SJ. Iridocyclitis associated with juvenile rheumatoid arthritis. Am J Ophthalmol. 1975;80:425-429.
8. Dana MR, Merayo-Lloves J, Schaumberg DA. et al. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997;104:236-244.
9. Cassidy JT, Levinson JE, Bass JC, et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum. 1986;29:274-281.
10. Foster CS, Barrett F. Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Ophthalmology. 1993;100:809-817.
11. van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002;13(10):777-787.
12. Lard LR, Visser H, Speyer I, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med. 2001;111:446-451.
13. Borg G, Allander E, Lund B, et al. Auranofin improves outcome in early rheumatoid arthritis: results from a 2-year, double-blind placebo controlled study. J Rheumatol. 1988;15:1747-1754.
14. van der Heijde DM, Jacobs JW, Bijlsma JW, et al. The effectiveness of early treatment with 'second-line' antirheumatic drugs: a randomized, controlled trial. Ann Intern Med. 1996;124:699-707.
15. Giannini EH, Brewer EJ, Kuzmina N, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N Engl J Med. 1992;326(16):1043- 1049.
16. Rose CD, Singsen BH, Eichenfield AH, et al. Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr. 1990;117(4):653-659.
17. Shetty AK, Zganjar BE, Ellis Jr GS, et al. Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis. J Pediatr Ophthalmol Strabismus. 1999;36(3):125-128.
18. Weiss AH, Wallace CA, Sherry DD. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis. J Pediatr. 1998;133(2):266-268.
19. Samson, CM, Waheed N, Foster CS. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology. 2001;108(6):1134-1139.
20. Foster CS, Tufail F, Waheed NK, Chu D, Miserocchi E, Baltatzis S, Vredeveld CM. Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate. Arch Ophthalmol. 2003;121:437-440.
21. Edelsten C, Lee V, Bentley CR, Kanski JJ, Graham EM. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002;86:51-56.
22. Özdal PC, Vianna RNG, Deschênes J. Visual outcome of juvenile rheumatoid arthritis associated uveitis in adults. Ocul Immunol Inflamm. 2005;13(1)33-38.
23. Sherry DD, Mellins ED, Wedgwood RJ. Decreasing severity of chronic uveitis in children with pauciarticular arthritis. Am J Dis Child. 1991;145:1026-1028.
24. Chalom EC, Goldsmith DP, Koehler MA, et al. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol. 1997;24:2031-2034.
25. Kotaniemi K, Kautiainen H, Karma A, Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology. 2001;108:2071-2075.
26. Rosenberg K, Feuer, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004;111:2299-2306.
27. Zak M, Fledelius H, Pedersen FK. Ocular complications and visual outcome in juvenile chronic arthritis: a 25-year follow-up study. Acta Ophthalmol Scand. 2003;81:211-215.